搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Zygosaccharomyces rouxii Phosphatidylethanolamine N-methyltransferase (CHO2), partial CSB-YP017780ZBL
CSB-EP017780ZBL
CSB-BP017780ZBL
CSB-MP017780ZBL
CSB-EP017780ZBL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermococcus sibiricus Mevalonate kinase (mvk) CSB-YP015247TMT
CSB-EP015247TMT
CSB-BP015247TMT
CSB-MP015247TMT
CSB-EP015247TMT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum Argininosuccinate lyase (argH) CSB-YP002213ESQ
CSB-EP002213ESQ
CSB-BP002213ESQ
CSB-MP002213ESQ
CSB-EP002213ESQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter sp. Uroporphyrinogen decarboxylase (hemE) CSB-YP025678GFR
CSB-EP025678GFR
CSB-BP025678GFR
CSB-MP025678GFR
CSB-EP025678GFR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ajellomyces capsulata Phosphatidylethanolamine N-methyltransferase (CHO2), partial CSB-YP017780AZA
CSB-EP017780AZA
CSB-BP017780AZA
CSB-MP017780AZA
CSB-EP017780AZA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Verticillium albo-atrum Eukaryotic translation initiation factor 6 (TIF6) CSB-YP007582VES
CSB-EP007582VES
CSB-BP007582VES
CSB-MP007582VES
CSB-EP007582VES-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sordaria macrospora Phosphatidylethanolamine N-methyltransferase (CHO2), partial CSB-YP017780FIM
CSB-EP017780FIM
CSB-BP017780FIM
CSB-MP017780FIM
CSB-EP017780FIM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ailuropoda melanoleuca Ectonucleoside triphosphate diphosphohydrolase 5 (ENTPD5), partial CSB-YP007694AYX1
CSB-EP007694AYX1
CSB-BP007694AYX1
CSB-MP007694AYX1
CSB-EP007694AYX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Hydroxyacylglutathione hydrolase (gloB) CSB-YP010121EJO
CSB-EP010121EJO
CSB-BP010121EJO
CSB-MP010121EJO
CSB-EP010121EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Teredinibacter turnerae Aminomethyltransferase (gcvT) CSB-YP001684TLR
CSB-EP001684TLR
CSB-BP001684TLR
CSB-MP001684TLR
CSB-EP001684TLR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Kosmotoga olearia Adenine phosphoribosyltransferase (apt) CSB-YP001954KBR
CSB-EP001954KBR
CSB-BP001954KBR
CSB-MP001954KBR
CSB-EP001954KBR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermococcus sibiricus Glyceraldehyde-3-phosphate dehydrogenase (gap) CSB-YP009232TMT
CSB-EP009232TMT
CSB-BP009232TMT
CSB-MP009232TMT
CSB-EP009232TMT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum Uroporphyrinogen decarboxylase (hemE) CSB-YP025678ESQ
CSB-EP025678ESQ
CSB-BP025678ESQ
CSB-MP025678ESQ
CSB-EP025678ESQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Phosphatidylethanolamine N-methyltransferase (CHO2), partial CSB-YP017780SVL
CSB-EP017780SVL
CSB-BP017780SVL
CSB-MP017780SVL
CSB-EP017780SVL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermococcus gammatolerans Mevalonate kinase (mvk) CSB-YP015247TMP
CSB-EP015247TMP
CSB-BP015247TMP
CSB-MP015247TMP
CSB-EP015247TMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Aminomethyltransferase (gcvT) CSB-YP001684EJO
CSB-EP001684EJO
CSB-BP001684EJO
CSB-MP001684EJO
CSB-EP001684EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Argininosuccinate lyase (argH) CSB-YP002213EJO
CSB-EP002213EJO
CSB-BP002213EJO
CSB-MP002213EJO
CSB-EP002213EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Uroporphyrinogen decarboxylase (hemE) CSB-YP025678EJO
CSB-EP025678EJO
CSB-BP025678EJO
CSB-MP025678EJO
CSB-EP025678EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus Uroporphyrinogen decarboxylase (hemE) CSB-YP025678VEM
CSB-EP025678VEM
CSB-BP025678VEM
CSB-MP025678VEM
CSB-EP025678VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Variovorax paradoxus CTP synthase (pyrG), partial CSB-YP006176VEM
CSB-EP006176VEM
CSB-BP006176VEM
CSB-MP006176VEM
CSB-EP006176VEM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>